Ladenburg Thalmann Financial Services’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $3K | Buy |
1,100
+100
| +10% | +$273 | ﹤0.01% | 5027 |
|
|
2019
Q3 | $3K | Sell |
1,000
-500
| -33% | -$1.5K | ﹤0.01% | 4918 |
|
|
2019
Q2 | $4K | Hold |
1,500
| – | – | ﹤0.01% | 4830 |
|
|
2019
Q1 | $6K | Hold |
1,500
| – | – | ﹤0.01% | 4616 |
|
|
2018
Q4 | $5K | Hold |
1,500
| – | – | ﹤0.01% | 4642 |
|
|
2018
Q3 | $9K | Buy |
1,500
+500
| +50% | +$3K | ﹤0.01% | 4363 |
|
|
2018
Q2 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 4625 |
|
|
2018
Q1 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 4625 |
|
|
2017
Q4 | $6K | Sell |
1,000
-21,000
| -95% | -$126K | ﹤0.01% | 4479 |
|
|
2017
Q3 | $122K | Sell |
22,000
-1,000
| -4% | -$5.55K | ﹤0.01% | 2473 |
|
|
2017
Q2 | $107K | Buy |
23,000
+22,000
| +2,200% | +$102K | ﹤0.01% | 2475 |
|
|
2017
Q1 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 4340 |
|
|
2016
Q4 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 3856 |
|
|
2016
Q3 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 3908 |
|
|
2016
Q2 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 4073 |
|
|
2016
Q1 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 3928 |
|
|
2015
Q4 | $8K | Sell |
1,000
-500
| -33% | -$4K | ﹤0.01% | 3835 |
|
|
2015
Q3 | $11K | Buy |
1,500
+750
| +100% | +$5.5K | ﹤0.01% | 3490 |
|
|
2015
Q2 | $8K | Buy |
750
+250
| +50% | +$2.67K | ﹤0.01% | 3846 |
|
|
2015
Q1 | $5K | Hold |
500
| – | – | ﹤0.01% | 4011 |
|
|
2014
Q4 | $4K | Buy |
+500
| New | +$4K | ﹤0.01% | 3855 |
|